Dilator

Information

  • Patent Grant
  • 8845726
  • Patent Number
    8,845,726
  • Date Filed
    Thursday, January 22, 2009
    15 years ago
  • Date Issued
    Tuesday, September 30, 2014
    10 years ago
Abstract
A dilator that facilitates implantation of an interspinous spacer is provided. The dilator includes a proximal portion and a tapered distal portion interconnected by an elongated body portion. The tapered distal portion is ideally suited for splitting ligamentous tissue for creating a posterior midline pathway through the supraspinous ligament as well as for distracting the adjacent spinous processes. Two oppositely located and longitudinally extending channels or grooves are formed in the outer surface of the dilator for stabilizing the dilator with respect to the spinous processes. An accompanying cannula together with the dilator form a system for the distraction of the adjacent spinous processes, stabilization of the spinous processes with respect to the system and creation of a working channel for the implantation of an interspinous spacer.
Description
BACKGROUND

A variety of retractors and dilation systems have been used to provide a traditional “open” or “mini-open” approach to the posterior spine, as well as for providing the more modern “minimally invasive” and “percutaneous” access to the spine. The “open” or “mini-open” approaches to the spine typically require larger incisions. These larger incisions readily provide visual and instrument access to the surgical site; however, larger incisions generally result in greater damage to muscle tissue, blood loss, long healing times accompanied by prolonged pain and significant scarring.


The development of minimally invasive, percutaneous procedures has provided a major improvement in reducing recovery time and post operative-pain. In minimally invasive, percutaneous techniques patient trauma is minimized by creating a relatively smaller incision, followed by the introduction of a series of successfully larger dilators installed in sequence to dilate the soft tissues and increase the effective size of the incision. In some cases, a guide wire is used to first access the surgical site and then cannulated dilators are installed over the wire. Following installation of the largest dilator deemed necessary, a cannula or retractor is advanced over the largest dilator for providing a working channel from the skin of the patient to the working space adjacent to the spine. Surgery is performed or an implant is inserted through a surgical port or cannula inserted into the dilated incision.


Instead of cutting a larger opening, sequential dilation splits the surrounding tissue to create a larger opening. Splitting the muscle fibers apart, rather than cutting the muscle causes less damage to the tissue and leads to faster recovery times and reduced patient discomfort. Also, sequential dilation provides an advantage in that it allows the surgeon to make an initially small incision, then gradually increase the size of the opening to the minimum size required for performing the surgical procedure, thus reducing tissue damage and speeding patient recovery time.


Certain spinal procedures, such as those developed by VertiFlex, Inc. and described in U.S. patent application Ser. No. 11/314,712 entitled “Systems and methods for posterior dynamic stabilization of the spine” filed on Dec. 20, 2005 and U.S. patent application Ser. No. 11/582,874 entitled “Minimally invasive tooling for delivery of interspinous spacer” filed on Oct. 18, 2006 and U.S. patent application Ser. No. 11/593,995 entitled “Systems and methods for posterior dynamic stabilization of the spine” filed on Nov. 7, 2006, U.S. patent application Ser. No. 12/148,104 entitled “Interspinous spacer” filed on Apr. 16, 2008, U.S. patent application Ser. No. 12/217,662 entitled “Interspinous spacer” filed on Jul. 8, 2008, U.S. patent application Ser. No. 12/220,427 entitled “Interspinous spacer” filed on Jul. 24, 2008, U.S. patent application Ser. No. 12/205,511 entitled “Interspinous spacer” filed on Sep. 5, 2008, U.S. patent application Ser. No. 12/338,793 entitled “Interspinous spacer” filed on Dec. 18, 2008, U.S. patent application Ser. No. 12/354,517 entitled “Interspinous spacer” filed on Jan. 15, 2009, all of which are incorporated herein by reference in their entireties, access the surgical site through tissue and through the supraspinous ligament, for example, for the insertion of a device, such as an interspinous spacer. Whereas the procedure may be performed in an open, mini-open or minimally invasive, percutaneous approach, penetrating the supraspinous ligament can be challenging as the ligamentous tissue is not only strong but also slippery. However, penetrating the supraspinous ligament particularly lends itself well to sequential dilation as the ligament is formed of a cord of substantially uniformly oriented fibrous strands that are advantageously capable of being split apart rather than transversely cut for minimizing trauma and increasing patient recovery time. Furthermore, approaching the interspinous process space through the supraspinous ligament, like the VertiFlex device, advantageously avoids the multifidus muscle and thereby preserves its critical function as a stabilizer of the lumbar spine. Because of the difficulties associated with penetrating ligament, there is a special need for a dilator and/or dilator system designed for accessing a surgical site through ligament such as the supraspinous or interspinous ligament. The current invention provides a dilator and dilator system for establishing an opening through ligament that may also be used in conjunction with minimally invasive, percutaneous procedures.


SUMMARY

According to one aspect of the invention, a dilator comprising a proximal portion and a distal portion interconnected by an elongated body portion is provided. At least a part of the distal portion has a cross-sectional area decreasing with distance towards the distal end. Two oppositely located channels are formed in the body portion and extend longitudinally into the distal portion.


A system comprising a dilator and a cannula is provided. The dilator comprises a proximal portion and a distal portion interconnected by an elongated body portion. At least a part of the distal portion has a cross-sectional area decreasing with distance towards the distal end. Two oppositely located channels are formed in the body portion and extend longitudinally into the distal portion. The cannula includes two oppositely located channels on the outer surface and has a passageway configured to receive the dilator.


A method is provided comprising the steps of inserting a dilator into a patient via a posterior midline approach between two adjacent spinous processes and distracting the adjacent spinous processes by advancing the dilator relative to the adjacent spinous processes.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1
a is a side view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 1
b is a top view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 1
c is a perspective view of a distal end of a dilator according to the present invention.



FIG. 1
d is an end view of a distal end of a dilator according to the present invention.



FIG. 1
e is a cross-sectional view of the distal end of a dilator according to the present invention.



FIG. 2
a is a side view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 2
b is a top view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 2
c is a perspective view of a distal end of a dilator according to the present invention.



FIG. 2
d is an end view of a distal end of a dilator according to the present invention.



FIG. 2
e is a cross-sectional view of the distal end of a dilator according to the present invention.



FIG. 3
a is a side view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 3
b is a top view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 3
c is a perspective view of a distal end of a dilator according to the present invention.



FIG. 3
d is an end view of a distal end of a dilator according to the present invention.



FIG. 3
e is a cross-sectional view of the distal end of a dilator according to the present invention.



FIG. 4
a is a side view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 4
b is a top view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 4
c is a perspective view of a distal end of a dilator according to the present invention.



FIG. 4
d is an end view of a distal end of a dilator according to the present invention.



FIG. 4
e is a cross-sectional view of the distal end of a dilator according to the present invention.



FIG. 5
a is a side view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 5
b is a top view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 5
c is a perspective view of a distal end of a dilator according to the present invention.



FIG. 5
d is an end view of a distal end of a dilator according to the present invention.



FIG. 5
e is a cross-sectional view of the distal end of a dilator according to the present invention.



FIG. 6
a is a side view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 6
b is a top view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 6
c is a perspective view of a distal end of a dilator according to the present invention.



FIG. 6
d is an end view of a distal end of a dilator according to the present invention.



FIG. 7
a is a side view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 7
b is a top view of a dilator and an enlarged portion of the distal end of the dilator according to the present invention.



FIG. 7
c is a perspective view of a distal end of a dilator according to the present invention.



FIG. 7
d is an end view of a distal end of a dilator according to the present invention.



FIG. 8
a is a side view of a cannula according to the present invention.



FIG. 8
b is a perspective view of a distal end of a cannula according to the present invention.





DETAILED DESCRIPTION

While the description of the dilator system of this invention will be discussed primarily in relation to spinal surgery, it should be understood that the system will find use in other areas of surgery in which a surgeon wishes to gain access to an internal cavity by cutting the skin and enlarging an incision in a body wall so that surgical instruments can be inserted to perform a desired surgical procedure. For example, the dilator system may be used to create an incision to provide access to the posterior spine through which pedicle screws may be percutaneously installed in one or more selected vertebra. Alternatively, the dilator system may be used to create an incision to access an invertebral disc space for performance of a minimally invasive discectomy procedure and/or spinal fusion procedure including the implantation of one or more intervertebral or interspinous process implants.


Implants are inserted between adjacent spinous processes to distract the spine segments and maintain them in a position to relieve symptoms of spinal stenosis and other conditions that cause pain which is associated with the back. Such implants have a spacer which remains in place between the adjacent spinous processes. An opening is created in the supraspinous and/or interspinous ligament so that the implant can be inserted. The dilators of the present invention are used to step dilate or gradually dilate body tissue, in particular, the supraspinous and/or interspinous ligament.


The dilator system of the present invention includes one or more dilators configured to work independently or in conjunction with one another. When used in conjunction with one another a first dilator is generally smaller in outer diameter or cross-sectional area than that of a second dilator which typically is also cannulated so that the second dilator fits over the first dilator to dilate tissue. It should be noted that the second dilator, in one variation, is not cannulated but is sized larger than the first dilator. In such a variation, the first dilator is removed and the second dilator is inserted to expand body tissue. In another variation, the first dilator is cannulated to be placed over a guide wire that is first positioned in the patient. In any of the variations disclosed herein, the first dilator may also be cannulated. Although in some cases two dilators are discussed it should be noted that more than two dilators may be employed in any of the variations disclosed herein. Furthermore, some of the distal ends of the dilators of the present invention are sufficiently sharp or manufactured with integrated knife points to cut tissue without a need for a separate instrument such as a scalpel to create an initial incision in the skin or ligament which is then expanded with the dilators, whereas other dilators of the present invention have a distal end that is too blunt and a separate instrument such as a scalpel is employed to create the first incision in the tissue or ligament.


With reference to FIG. 1a, there is shown a dilator 10 according to the present invention. The dilator 10 has an elongated body 12, a proximal end 14 and a distal end 16. The dilator 10 includes a pair of channels 18 shown in FIGS. 1b, 1c and 1e that are oppositely located from each other and run parallel to the longitudinal axis of the dilator 10. The distal end 20 of the channel 18 commences in the distal end 16 and the proximal end 22 of the channel 18 ends in the body 12 portion of the dilator 10. In one variation, the channel 18 has a flat base between two sidewalls. When inserted in a patient and aligned with the adjacent spinous processes, the channels 18 are advantageous for distracting the spinous processes apart as well as for keeping the dilator 10 in position between the spinous processes while being inserted especially in a “kissing” condition of the spine where the posterior tips of adjacent spinous processes are in close proximity, touch or “kiss”. In one variation, the channels 18 are absent from the dilator 10. The distal end 16 of the dilator 10 is a tapered portion where the diameter or cross-sectional area is less than the diameter or cross-sectional area of the body portion 12. In the embodiment shown in FIGS. 1a-1e, the distal end 16 portion has a cone shape shown in FIG. 1c. An end view of the distal end 16 is shown in FIG. 1d illustrating the tip or point 24 of the cone or bore 24 in a cannulated version of the dilator. When a cross-section of the distal end 16 is taken at a location distal to the channels 18 and perpendicular to the longitudinal axis of the dilator 10 as shown in FIG. 1e, the cross-sectional area 26 of the distal end 16 is circular in shape. The cone-shaped dilator of FIGS. 1a-1e is generally employed as a first dilator 10 and may be cannulated for passing over a guide wire or if used as a subsequent dilator for passing over a previous dilator. The cone-shaped dilator 10 shown in FIG. 1 punctures ligament and passes through soft tissue easily and therefore, it can be used as a first dilator in a minimally invasive percutaneous procedure without the need to first create a cut with a separate sharp edge such as a scalpel. A sharper tip formed by a distal end 16 with a more acute angle Θ (see FIG. 1b) will prevent the tip 24 from slipping off to the sides of the ligament.


Turning now to FIGS. 2a-2e, there is shown another variation of a dilator 10 according to the present invention wherein like reference numbers are used to describe like parts. Referring first to FIG. 2a, the dilator 10 has an elongated body 12, a proximal end 14 and a distal end 16. The dilator 10 includes a pair of channels 18 shown in FIGS. 2b, 2c and 2e that are oppositely located from each other and run parallel to the longitudinal axis of the dilator 10. The distal end 20 of the channel 18 commences in the distal end 16 and the proximal end 22 of the channel 18 ends in the body 12 portion of the dilator 10. When inserted in a patient and aligned with the adjacent spinous processes, the channels 18 are advantageous for distracting the spinous processes apart as well as for keeping the dilator 10 in position between adjacent spinous processes while being inserted especially in a “kissing” condition of the spine where the posterior tips of adjacent spinous processes are in close proximity, touch or “kiss”. In one variation, the channels 18 are absent from the dilator 10. The distal end 16 of the dilator 10 is a tapered portion where the diameter or cross-sectional area is less than the diameter or cross-sectional area of the body portion 12 and decreases toward the distal end 16. In the embodiment shown in FIGS. 2a-2e, the distal end 16 portion has a wedge shape formed by two substantially flat faces 28 that angle towards each other at the distal end 16 and form a line or rectangular tip 24 shown in FIG. 2d. An end view of the distal end 16 is shown in FIG. 2d illustrating the line or rectangular tip 24 of the wedge. A cannulated variation of the dilator 10 is not shown but is within the scope of the present invention. When a cross-section of the distal end 16 is taken at a location distal to the channels 18 and perpendicular to the longitudinal axis of the dilator 10 as shown in FIG. 2e, the cross-sectional area 26 of the distal end 16 is rectangular in shape. The wedge-shaped dilator of FIGS. 2a-2e is generally employed as a first dilator 10 and may be cannulated for passing over a guide wire or if used as a subsequent dilator for passing over a previous dilator. The distal end 16 is positioned in the patient such that the length of the tip 24 is aligned along the cephalad-caudal direction when puncturing the supraspinous ligament or otherwise aligned substantially parallel to the fibrous strands of the ligament. The wedge-shaped dilator 10 shown in FIGS. 2a-2e does not puncture ligament as readily as the dilator 10 of FIGS. 1a-1e and hence, is typically used in conjunction with a scalpel or other sharp edge, for example, to create a small opening in the ligament prior to insertion of the dilator 10 of FIGS. 2a-2e which then splits the ligament to create a larger opening as it is inserted. For these reasons, the dilator of FIGS. 2a-2e is generally used as a first dilator in a mini-open or open procedure in which direct visual access is gained and a sharp edge is used to first create a cut. The line or rectangular shaped point 24 is centered as seen in FIGS. 2d and 2e and therefore advantageously assists in centering the location of the splitting on the ligament. It should be noted that a sharper tip may be formed by a distal end 16 with a more acute angle Θ (see FIG. 2b) thereby, creating or a approaching a knife-like edge that can pierce the ligament without first using a sharp edge and therefore well suited for truly percutaneous procedures.


Turning now to FIGS. 3a-3e, there is shown another variation of a dilator 10 according to the present invention wherein like reference numbers are used to describe like parts. Referring first to FIG. 3a, the dilator 10 has an elongated body 12, a proximal end 14 and a distal end 16. The dilator 10 includes a pair of channels 18 shown in FIGS. 3b, 3c, 3d and 3e that are oppositely located from each other and run parallel to the longitudinal axis of the dilator 10. The distal end 20 of the channel 18 commences in the distal end 16 and the proximal end 22 of the channel 18 ends in the body 12 portion of the dilator 10. When inserted in a patient and aligned with the adjacent spinous processes, the channels 18 are advantageous for distracting the spinous processes apart as well as for keeping the dilator 10 in position between the spinous processes while being inserted especially in a “kissing” condition of the spine where the posterior tips of adjacent spinous processes are in close proximity, touch or “kiss”. In one variation, the channels 18 are absent from the dilator 10. The distal end 16 of the dilator 10 is a tapered portion where the diameter or cross-sectional area is less than the diameter or cross-sectional area of the body portion 12 and decreases towards the distal end 16. In the embodiment shown in FIGS. 3a-3e, the distal end 16 portion has a pyramid shape formed by four substantially flat faces 28 that angle towards each other at the distal end 16 and meet at a tip 24 shown in FIGS. 3c and 3d. An end view of the distal end 16 is shown in FIG. 3d illustrating the tip 24 of the pyramid-shaped distal end 16. A cannulated variation of the dilator 10 is not shown but is within the scope of the present invention wherein the tip 24 would include an opening. When a cross-section of the distal end 16 is taken at a location distal to the channels 18 and perpendicular to the longitudinal axis of the dilator 10 as shown in FIG. 3e, the cross-sectional area 26 of the distal end 16 is substantially square in shape. The pyramid-shaped dilator of FIGS. 3a-3e is generally employed as a first dilator 10 and may be cannulated for passing over a guide wire or if used as a subsequent dilator for passing over a previous dilator. The pyramid-shaped dilator 10 shown in FIGS. 3a-3e can puncture ligament and pass through soft tissue and hence, is generally used as a first dilator in a minimally invasive percutaneous procedure without the need to first create a cut with a separate sharp edge such as a scalpel. A sharper tip formed by a distal end 16 with a more acute angle Θ (see FIG. 3b) will prevent the tip 24 from slipping off to the sides of the ligament.


Turning now to FIGS. 4a-4e, there is shown another variation of a dilator 10 according to the present invention wherein like reference numbers are used to describe like parts. Referring first to FIG. 4a, the dilator 10 has an elongated body 12, a proximal end 14 and a distal end 16. The dilator 10 includes a pair of channels 18 shown in FIGS. 4b, 4c, 4d and 4e that are oppositely located from each other and run parallel to the longitudinal axis of the dilator 10. The distal end 20 of the channel 18 commences in the distal end 16 and the proximal end 22 of the channel 18 ends in the body 12 portion of the dilator 10. When inserted in a patient and aligned with the adjacent spinous processes, the channels 18 are advantageous for distracting the spinous processes apart as well as for keeping the dilator 10 in position between the spinous processes while being inserted especially in a “kissing” condition of the spine where the posterior tips of adjacent spinous processes are in close proximity, touch or “kiss”. In one variation, the channels 18 are absent from the dilator 10. The distal end 16 of the dilator 10 is a tapered portion where the diameter or cross-sectional area is less than the diameter or cross-sectional area of the body portion 12 and decreases toward the distal end 16. In the embodiment shown in FIGS. 4a-4e, the distal end 16 portion has a pyramid shape formed by four substantially flat faces 28 that angle towards each other at the distal end 16 and form a tip 24 shown in FIG. 4d. An end view of the distal end 16 is shown in FIG. 4d illustrating the tip 24 of the pyramid. A cannulated variation of the dilator 10 is not shown but is within the scope of the present invention wherein the tip 24 would include an opening. When a cross-section of the distal end 16 is taken at a location distal to the channels 18 and perpendicular to the longitudinal axis of the dilator 10 as shown in FIG. 4e, the cross-sectional area 26 of the distal end 16 is a quadrilateral and, in the variation shown in FIG. 4e, the quadrilateral is a rhombus in which one of the diagonals 30 or the longest diagonal 30 is aligned with the channels 18 as opposed to the variation of FIGS. 3a-3e in which none of the diagonals are aligned with the channels 18. It is the intersection of two faces 28 that align with one channel 18 and the intersection of opposite two faces 28 that align with the other channel 18. In a variation in which no channels 18 are included, the difference between the dilator of FIGS. 3a-3e is in the shape of the quadrilateral. The pyramid-shaped dilator of FIGS. 4a-4e is generally employed as a first dilator 10 and may be cannulated for passing over a guide wire or if used as a subsequent dilator for passing over a previous dilator. The distal end 16 is positioned in the patient such that one of the diagonals or longest diagonal 30 is aligned along the cephalad-caudal direction when puncturing the supraspinous ligament or otherwise aligned substantially parallel to the fibrous strands of the ligament such that the intersection of faces 28 form an edge along which ligament is split. The pyramid-shaped dilator 10 shown in FIGS. 4a-4e in either the channeled or non-channeled variations, splits ligament more readily than either of the channeled or non-channeled variations of the dilator 10 of FIGS. 3a-3e where the intersections of faces 28 are not aligned with the channels 18 or does not have a diagonal 30 that is longer relative to the other diagonal 30 which can be aligned with the fibrous ligament strands for easier splitting. The variation of FIGS. 4a-4e can be used with or without a scalpel or other sharp edge, for example, to create a small opening in the ligament prior to insertion of the dilator 10 of FIGS. 4a-4e which then splits the ligament to create a larger opening as it is inserted. The intersection of faces 28 or diagonal 30, when aligned substantially parallel to the ligament strands, assist in centering the location of the splitting on the ligament. It should be noted that a sharper tip, intersection or diagonal may be formed by a distal end 16 with a more acute angle Θ (see FIG. 4b) thereby, creating or a approaching a knife-like edge that can pierce the ligament without first using a sharp edge and therefore well suited for percutaneous procedures.


Turning now to FIGS. 5a-5e, there is shown another variation of a dilator 10 according to the present invention wherein like reference numbers are used to describe like parts. Referring first to FIG. 5a, the dilator 10 has an elongated body 12, a proximal end 14 and a distal end 16. The dilator 10 includes a pair of channels 18 shown in FIGS. 5b, 5c, 5d and 5e that are oppositely located from each other and run parallel to the longitudinal axis of the dilator 10. The distal end 20 of the channel 18 commences in the distal end 16 and the proximal end 22 of the channel 18 ends in the body 12 portion of the dilator 10. When inserted in a patient and aligned with the adjacent spinous processes, the channels 18 are advantageous for distracting the spinous processes apart as well as for keeping the dilator 10 in position between the spinous processes while being inserted especially in a “kissing” condition of the spine where the posterior tips of adjacent spinous processes are in close proximity, touch or “kiss”. In one variation, the channels 18 are absent from the dilator 10. The distal end 16 of the dilator 10 is a tapered portion where the diameter or cross-sectional area is less than the diameter or cross-sectional area of the body portion 12 and decreases toward the distal end 16. In the embodiment shown in FIGS. 5a-5e, the distal end 16 portion has two curved faces 28 that angle towards each other at the distal end 16 and form a tip 24 shown in FIG. 5d. An end view of the distal end 16 is shown in FIG. 5d illustrating the tip 24. A cannulated variation of the dilator 10 is not shown but is within the scope of the present invention wherein the tip 24 would include an opening. In yet another variation, the tip 24 includes an opening to a blade housing through which a blade may extend. The blade (not shown) may also be retractable. When a cross-section of the distal end 16 is taken at a location distal to the channels 18 and perpendicular to the longitudinal axis of the dilator 10 as shown in FIG. 5e, the cross-sectional area 26 of the distal end 16 is comprised of an area bounded by two curved lines in which the length is aligned with the channels 18. It is the intersections of two faces 28 that align with one channel 18. In a variation in which no channels 18 are included, the length is aligned with the length of the ligament. The dilator 10 of FIGS. 5a-5e is generally employed as a first dilator 10 and may be cannulated for passing over a guide wire or if used as a subsequent dilator for passing over a previous dilator. The distal end 16 is positioned in the patient such that the length of the tip 24 is aligned along the cephalad-caudal direction when puncturing the supraspinous ligament or otherwise aligned substantially parallel to the fibrous strands of the ligament or to the ligament itself such that the intersections of faces 28 form an edge along which ligament is split. The variation of FIGS. 5a-5e can be used with or without a scalpel or other sharp edge, for example, to create a small opening in the ligament prior to insertion of the dilator 10 of FIGS. 5a-5e which then splits the ligament to create a larger opening as it is inserted. The intersection of faces 28 when aligned substantially parallel to the ligament strands, assist in centering the location of the splitting on the ligament. It should be noted that a sharper tip, intersection or diagonal may be formed by a distal end 16 with a more acute angle Θ (see FIG. 5b) thereby, creating or a approaching a knife-like edge that can pierce the ligament without first using a sharp edge and therefore well suited for percutaneous procedures.


Turning now to FIGS. 6a-6d, there is shown another variation of a dilator 10 according to the present invention wherein like reference numbers are used to describe like parts. Referring first to FIG. 6a, the dilator 10 has an elongated body 12, a proximal end 14 and a distal end 16. The dilator 10 includes a pair of channels 18 shown in FIGS. 6b, 6c and 6d that are oppositely located from each other and run parallel to the longitudinal axis of the dilator 10. The distal end 20 of the channel 18 commences in the distal end 16 and the proximal end 22 of the channel 18 ends in the body 12 portion of the dilator 10. When inserted in a patient and aligned with the adjacent spinous processes, the channels 18 are advantageous for distracting the spinous processes apart as well as for keeping the dilator 10 in position between the spinous processes while being inserted especially in a “kissing” condition of the spine where the posterior tips of adjacent spinous processes are in close proximity, touch or “kiss”. In one variation, the channels 18 are absent from the dilator 10. The distal end 16 of the dilator 10 is a tapered portion where the diameter or cross-sectional area is less than the diameter or cross-sectional area of the body portion 12 and decreases toward the distal end 16. In the embodiment shown in FIGS. 6a-6d, the distal end 16 portion has a surface 28, that may also be curved that angles toward the distal end 16 and forms an opening 32 at tip 24 shown in FIGS. 6c and 6d. An end view of the distal end 16 is shown in FIG. 6d illustrating the opening 32 that forms distal end of the cannulation or bore 34 running along at least part of the length of the dilator 10. Because of the central bore 34 is sized to received therein a smaller dilator 10 such as any of the dilators described above in FIGS. 1-5, the dilator 10 of FIGS. 6a-6d is generally employed as a second dilator 10 or dilator 10 subsequent for passing over a previous dilator. The distal end 16 is positioned over a previous dilator 10 in the patient such that the channels 18 are aligned generally perpendicular to the cephalad-caudal direction when puncturing the supraspinous ligament or otherwise aligned substantially perpendicular to the fibrous strands of the ligament or to the ligament itself. When inserted, the cannula of FIGS. 6a-6d continues to distract the spinous processes as they ride in the channels 18 with the channels 18 helping with maintaining the proper orientation of the dilators 10 between the spinous processes. In one variation, the channels 18 are ramped or angled towards the distal end to improve upon the distraction action provided by the dilator.


Turning now to FIGS. 7a-7d, there is shown another variation of a dilator 10 according to the present invention wherein like reference numbers are used to describe like parts. Referring first to FIG. 7a, the dilator 10 has an elongated body 12, a proximal end 14 and a distal end 16. The dilator 10 includes a pair of channels 18 shown in FIGS. 7b, 7c and 7d that are oppositely located from each other and run parallel to the longitudinal axis of the dilator 10. The distal end 20 of the channel 18 commences in the distal end 16 and the proximal end 22 of the channel 18 ends in the body 12 portion of the dilator 10. In one variation, the channel 18 includes a flat base between two sidewalls. When inserted in a patient and aligned with the adjacent spinous processes, the channels 18 are advantageous for distracting the spinous processes apart as well as for keeping the dilator 10 in position between the spinous processes while being inserted especially in a “kissing” condition of the spine where the posterior tips of adjacent spinous process are in close proximity, touch or “kiss”. In one variation, the channels 18 are absent from the dilator 10. The distal end 16 of the dilator 10 is a tapered portion where the diameter or cross-sectional area is less than the diameter or cross-sectional area of the body portion 12 and decreases toward the distal end 16. In the embodiment shown in FIGS. 7a-7d, the distal end 16 portion has a surface 28 that may also be curved that angles toward the distal end 16 and forms an opening 32 at tip 24 shown in FIGS. 7c and 7d. An end view of the distal end 16 is shown in FIG. 7d illustrating the opening 32 that forms distal end of the cannulation or bore 34 running along at least part of the length of the dilator 10. Because of the central bore 34 is sized to received therein a smaller dilator 10 such as any of the dilators described above in FIGS. 1-5, the dilator 10 of FIGS. 7a-7d is generally employed as a second dilator 10 or dilator 10 subsequent for passing over a previous dilator. The distal end 16 is positioned over a previous dilator 10 in the patient such that the channels 18 are aligned generally perpendicular to the cephalad-caudal direction when puncturing the supraspinous ligament or otherwise aligned substantially perpendicular to the fibrous strands of the ligament or to the ligament itself. The dilator of FIGS. 7a-7d further includes a pair of oppositely located flats 36 that are aligned with the channels 18. At least part of the channel 18 is formed in the flats 36 and in one variation, the flat 36 is substantially parallel to the flat base of the channel 18. The flats 36 create a lower profile for the dilator 10 which is advantageous for insertion between closely spaced spinous processes. When inserted, the cannula of FIGS. 7a-7d continues to distract the spinous processes as they ride in the channels 18 with the channels 18 helping with maintaining the proper orientation of the dilators 10 between the spinous processes.


An entry point is selected on the patient's skin to obtain access to the targeted surgical site, and an incision of appropriate length is made through the dermal layers of a patient's body at the entry point. The length and depth of the incision may be larger depending on whether the clinician is using an open, mini-open, or minimally invasive, percutaneous approach. If a guide wire is used, the tip of the guide wire is then positioned within the incision and guided toward the spine using a cannulated T-handled trocar. If a ligament such as the supraspinous or interspinous ligament is to be punctured with a sharp edge other than with the dilator, the sharp edge or scalpel is used to create a small cut in the ligament. One of the first dilators, such as any one of the dilators 10 described above in reference to FIGS. 1-5, is then inserted (over the guidewire if one is used) into the incision and into the cut in the ligament (if the ligament is pre-cut with a scalpel or other sharp edge). The first dilator is properly oriented (such that diagonal or edges are aligned with ligamentous strands as described above) and further inserted to spread apart body tissue and/or pierce and/or split and/or cut the ligament. After the first dilator is inserted a second dilator, such as any one of the dilators 10 described above in reference to FIGS. 6-7, is then passed over the proximal end 14 of the first dilator and further passed over the first dilator into the incision to further spread apart tissue and/or split the ligament. Any number of additional dilators, that are preferably cannulated for passing over the one or more previous dilators, are then inserted. A dilator with a channel 18 is oriented such that one of the adjacent spinous processes is positioned inside the channel 18 and in one variation, the other of the adjacent spinous processes is tracked inside the oppositely located channel 18. Such placement of the dilator with respect to the spinous processes stabilizes the dilator with respect to the spine. Advancement of the dilator relative to the adjacent spinous processes, ramps the adjacent spinous processes first at the tip of the distal portion and then inside the channel 18 if one is employed to distract the adjacent spinous processes. Subsequent dilators placed over the previous dilator may further distract the spinous processes. In one variation, the channels 18 themselves may be flat or further ramped to further distract the adjacent spinous processes. After the desired amount of dilation with dilators is achieved, a cannula 40 of the type shown in FIGS. 8a-8b is passed over the last dilator 10 such that the dilators 10 are received in the cannula bore 42. The cannula 40 may further include oppositely located channels 44 for receiving the adjacent spinous processes, stabilizing the spinous processes with respect to the dilator and for further distraction of the adjacent spinous processes. The channels 44 are formed by four wings 46 extending outwardly from the surface. With the cannula 40 in place, the dilators 10 inside the cannula bore 42 are removed leaving an open cannula bore 42 through which surgery can be performed or an implant be inserted.


All publications mentioned anywhere herein are incorporated herein by reference as part of the detailed description of the present invention to disclose and describe the methods and/or materials in connection with which the publications are cited or in connection with the present invention. The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.


The preceding merely illustrates the principles of the invention. It will be appreciated that those skilled in the art will be able to devise various arrangements which, although not explicitly described or shown herein, embody the principles of the invention and are included within its spirit and scope.

Claims
  • 1. A dilator comprising: a proximal portion and a distal portion interconnected by an elongated body portion;at least a part of the distal portion has a cross-sectional area decreasing as the cross-sectional area gets closer to a distal end; andtwo oppositely located channels formed in the body portion and extending longitudinally into the distal portion, each channel configured to receive a spinous process of a human subject distracted by the distal portion and having a first end portion opposite a second end portion, wherein each of the first end portions commences in the distal portion and each of the second end portions terminates in the body portion at a location proximate to the distal portion,wherein the two oppositely located channels are positioned to receive the spinous processes distracted by the distal portion and are configured to hold the distracted spinous process when the distracted spinous processes are positioned between longitudinally-extending sidewalls of the channels extending distally and proximally past the distracted spinous processes and the body portion extends in a direction generally perpendicular to a cephalad-caused direction.
  • 2. The dilator of claim 1 wherein at least part of the distal portion is substantially pyramidal.
  • 3. The dilator of claim 1 wherein the distal portion includes four flat faces angled towards each other in a distal direction.
  • 4. The dilator of claim 3 wherein the four flat faces have a rhomboidal cross section taken perpendicular to a longitudinal axis of the dilator; the rhomboidal cross-section having a major diagonal aligned with each of the two channels.
  • 5. The dilator of claim 1 wherein the body portion includes two oppositely located flat surfaces extending longitudinally along at least a portion of the body portion, wherein each of the flat surfaces is located at a bottom of one of the channels.
  • 6. The dilator of claim 1 wherein each channel includes a flat base between the two longitudinally-extending sidewalls.
  • 7. The dilator of claim 6 wherein the body portion includes two flat surfaces formed on the body portion; one of the flat surfaces being substantially parallel to one of the flat base of one channel and the other of the flat surfaces being substantially parallel to the flat bases of the other channel.
  • 8. The dilator of claim 1 wherein: the distal portion of the body portion includes four generally planar surfaces, wherein the four planar surfaces angle towards each other in a direction extending towards the distal portion; andthe first end portion of each channel intersects at least one of the planar surfaces.
  • 9. The dilator of claim 8 the first end portion of each channel intersects two adjacent planar surfaces.
  • 10. The dilator of claim 8 wherein an intersection of a first one of the four generally planar surfaces and a second one of the four generally planar surfaces are aligned with the first end portion of a first one of the channels; andan intersection of a third one of the four generally planar surfaces and a fourth one of the four generally planar surfaces is aligned with the first end portion of a second one of the channels.
  • 11. The dilator of claim 1 wherein the distal portion is configured to be inserted between adjacent spinous processes in a spinal segment.
  • 12. The dilator of claim 1 wherein the channels are configured to cause distraction of the spinous processes when the spinous processes move along the channels.
  • 13. The dilator of claim 1 wherein each of the second end portions defines a depth that decreases in a proximal direction such that spinous processes received by the channels are distracted as the spinous processes move along the second end portions.
  • 14. The dilator of claim 1 wherein the locations at which the second end portions terminate in the body portion are closer to the distal end of the dilator than a proximal end of the dilator.
  • 15. The dilator of claim 1 wherein the longitudinally-extending sidewalls are spaced apart from one another such that the spinous processes between the longitudinally-extending sidewalls contact bottom surfaces of the channels to maintain distraction of the distracted spinous processes.
  • 16. The dilator of claim 1 wherein at least part of the distal portion is substantially conical.
  • 17. The dilator of claim 1 wherein the distal portion includes two flat faces angled towards each other in the a distal direction; each of the two flat faces being oppositely located between the two channels.
  • 18. The dilator of claim 17 wherein the two flat faces form a tip having a rectangular or line cross-section taken perpendicular to a longitudinal axis of the dilator.
  • 19. The dilator of claim 17 wherein the two flat faces form an intersection at the distal end of the dilator; the intersection being aligned with the two channels.
  • 20. The dilator of claim 19 wherein the intersection is a sharp edge.
  • 21. The dilator of claim 19 further including an opening along the intersection.
  • 22. The dilator of claim 1 wherein the dilator includes a passageway extending between an opening at the distal portion and an opening at the portion end.
  • 23. The dilator of claim 1 further including a retractable blade at the distal portion.
  • 24. A system comprising: a dilator comprising: a proximal portion and a distal portion interconnected by an elongated body portion, wherein at least a part of the distal portion has a distal end and a cross-sectional area that decreases as the cross-sectional area gets closer to the distal end; andtwo oppositely located channels formed in the body portion and extending longitudinally into the distal portion, each channel configured to receive a spinous process distracted by the distal portion and having a first end and a second end, wherein each of the first ends of the channels commences in the distal portion, wherein each channel is positioned to receive and hold the spinous process distracted by the distal portion; anda cannula including two oppositely located channels on an outer surface and having a passageway configured to receive the dilator, wherein the channels of the cannula are positioned relative to the channels of the dilator such that the distracted spinous processes move from the channels of the dilator to the respective channels of the cannula when the cannula is moved along the dilator.
  • 25. The system of claim 2 wherein the cannula is configured to receive the dilator inside the passageway such that the channels of the cannula are aligned with the channels of the dilator.
  • 26. A system comprising: a dilator including a proximal end;a distal portion that has a cross-sectional area that decreases towards a distal end of the dilator;an elongated body portion between the proximal end and the distal portion;a first channel configured to receive a first spinous process and including a distal first channel end at the distal portion and a proximal first channel end, the proximal first channel end is closer to the distal end of the dilator than the proximal end of the dilator; anda second channel spaced apart from the first channel and configured to receive a second spinous process, the second channel including a distal second channel end at the distal portion and a proximal second channel end, the proximal second channel end is closer to the distal end of the dilator than the proximal end of the dilator,wherein the first channel and the second channel are positioned to receive and laterally hold the respective first and second spinous processes distracted by the distal portion.
  • 27. The system of claim 26 wherein the proximal first and second channel ends are ramped.
  • 28. The system of claim 26 wherein the first and second channels are configured to distract the first spinous process and the second spinous process as the first spinous process and the second spinous process move in a proximal direction along the first channel and the second channel, respectively.
  • 29. The system of claim 26, further comprising a cannula including a passageway, a first cannula channel, and a second cannula channel, wherein the first cannula channel and the second cannula channel are configured to receive the first spinous process and the second spinous process, respectively, when the cannula is advanced along the dilator.
  • 30. The system of claim 29 wherein the first cannula channel is positioned to receive the first spinous process and the second cannula channel is positioned to receive the second spinous process when the cannula is moved along the dilator.
  • 31. The system of claim 26 wherein the distal portion is configured to pass through a supraspinous ligament while keeping the first channel and the second channel substantially perpendicular to a cephalad-caudal direction.
  • 32. The system of claim 26, further comprising: a guidewire positioned in a passageway of the dilator such that the guidewire is capable of being moved distally from the distal end of the dilator.
  • 33. A system for distracting a first spinous process and a second spinous process of a human subject, comprising: a dilator including a proximal portion;a distal portion configured to distract the first spinous process and the second spinous process;an elongated body portion between the proximal portion and the distal portion;a first channel positioned along the body portion and including longitudinally-extending first sidewalls spaced apart to be positioned on either side of the first spinous process distracted by the distal portion; anda second channel positioned along the body portion and spaced apart from the first channel, wherein the second channel includes longitudinally-extending second sidewalls spaced apart to be positioned on either side of the second spinous process distracted by the distal portion such that the first spinous process is between the first sidewalls of the first channel and the second spinous process is between the second sidewalls of the second channel while the dilator moves relative to the first and second spinous processes.
  • 34. The system of claim 33 wherein the first channel and the second channel are positioned on opposite sides of the dilator.
  • 35. The system of claim 33, further comprising a cannula including two cannula channels and a passageway configured to receive the dilator, wherein the cannula channels are positioned such that the first and second spinous processes move from the channels of the dilator to the cannula channels when the cannula is advanced along the dilator.
  • 36. The system of claim 33 wherein the longitudinally-extending first sidewalls of the first channel and the longitudinally-extending second sidewalls of the second channel are oriented to extend distally and proximally past the first and second spinous processes such that the first spinous process is positioned directly between the first sidewalls of the first channel and the second spinous process is positioned directly between the second sidewalls of the second channel when the dilator is advanced distally into the subject.
  • 37. The system of claim 33 wherein each channel has a flat bottom.
CROSS-REFERENCE TO RELATED APPLICATIONS

This patent application claims priority to and the benefit of and is a continuation-in-part of U.S. Provisional Patent Application Ser. No. 61/062,448 entitled “Dilator” filed on Jan. 23, 2008 which is incorporated herein by reference in its entirety. This application also claims priority to and is a continuation-in-part of U.S. patent application Ser. No. 11/582,874 entitled “Minimally invasive tooling for delivery of interspinous spacer” filed on Oct. 18, 2006 and now issued as U.S. Pat. No. 8,128,662,which is incorporated herein by reference in its entirety.

US Referenced Citations (464)
Number Name Date Kind
2248054 Becker Jul 1941 A
2677369 Knowles May 1954 A
3242120 Steuber Mar 1966 A
3648691 Lumb et al. Mar 1972 A
3986383 Petteys Oct 1976 A
4632101 Freedland Dec 1986 A
4685447 Iversen et al. Aug 1987 A
4799484 Smith et al. Jan 1989 A
4895564 Farrell Jan 1990 A
5011484 Breard et al. Apr 1991 A
5015247 Michelson May 1991 A
5019081 Watanabe May 1991 A
5059193 Kuslich Oct 1991 A
5092866 Breard et al. Mar 1992 A
5178628 Otsuka et al. Jan 1993 A
5180393 Commarmond et al. Jan 1993 A
5182281 Frigola-Constansa et al. Jan 1993 A
5188281 Fujiwara et al. Feb 1993 A
5192281 de la Caffiniere Mar 1993 A
5195526 Michelson Mar 1993 A
5298253 LeFiles et al. Mar 1994 A
5368594 Martin et al. Nov 1994 A
5390683 Pisharodi Feb 1995 A
5415661 Holmes May 1995 A
5456722 McLeod et al. Oct 1995 A
5462738 LeFiles et al. Oct 1995 A
5472452 Trott Dec 1995 A
5484437 Michelson Jan 1996 A
5487739 Aebischer et al. Jan 1996 A
5489308 Kuslich et al. Feb 1996 A
5496318 Howland et al. Mar 1996 A
5531748 de la Caffiniere et al. Jul 1996 A
5549679 Kuslich Aug 1996 A
5571189 Kuslich Nov 1996 A
5591165 Jackson Jan 1997 A
5609634 Voydeville et al. Mar 1997 A
5609636 Kohrs et al. Mar 1997 A
5645599 Samani et al. Jul 1997 A
5654599 Casper Aug 1997 A
5658337 Kohrs et al. Aug 1997 A
5674295 Ray et al. Oct 1997 A
5700264 Zucherman et al. Dec 1997 A
5725582 Bevan et al. Mar 1998 A
5741253 Michelson Apr 1998 A
5762629 Kambin Jun 1998 A
5836948 Zucherman et al. Nov 1998 A
5860977 Zucherman et al. Jan 1999 A
5863948 Epstein et al. Jan 1999 A
5876404 Zucherman et al. Mar 1999 A
RE36211 Nonomura May 1999 E
5904636 Chen et al. May 1999 A
5904686 Zucherman et al. May 1999 A
5928207 Pisano et al. Jul 1999 A
5972015 Scribner et al. Oct 1999 A
6039761 Li et al. Mar 2000 A
6045552 Zucherman et al. Apr 2000 A
6048342 Zucherman et al. Apr 2000 A
6066154 Reiley et al. May 2000 A
6068630 Zucherman et al. May 2000 A
6074390 Zucherman et al. Jun 2000 A
6080155 Michelson Jun 2000 A
6080157 Cathro et al. Jun 2000 A
6090112 Zucherman et al. Jul 2000 A
6096038 Michelson Aug 2000 A
6102928 Bonutti Aug 2000 A
D433193 Gaw et al. Oct 2000 S
6132464 Martin et al. Oct 2000 A
6149642 Gerhart et al. Nov 2000 A
6149652 Zucherman et al. Nov 2000 A
6152926 Zucherman et al. Nov 2000 A
6156038 Zucherman et al. Dec 2000 A
6159215 Urbahns et al. Dec 2000 A
6179873 Zientek Jan 2001 B1
6183471 Zucherman et al. Feb 2001 B1
6190387 Zucherman et al. Feb 2001 B1
6225048 Soderberg-Naucler et al. May 2001 B1
6235030 Zucherman et al. May 2001 B1
6238397 Zucherman et al. May 2001 B1
6264651 Underwood et al. Jul 2001 B1
6264656 Michelson Jul 2001 B1
6267765 Taylor et al. Jul 2001 B1
6270498 Michelson Aug 2001 B1
6280444 Zucherman et al. Aug 2001 B1
6312431 Asfora Nov 2001 B1
6332882 Zucherman et al. Dec 2001 B1
6332883 Zucherman et al. Dec 2001 B1
6336930 Stalcup et al. Jan 2002 B1
6348053 Cachia Feb 2002 B1
6364883 Santilli Apr 2002 B1
6371989 Chauvin et al. Apr 2002 B1
6375682 Fleischmann et al. Apr 2002 B1
6379355 Zucherman et al. Apr 2002 B1
6395032 Gauchet et al. May 2002 B1
6402740 Ellis et al. Jun 2002 B1
6402750 Atkinson et al. Jun 2002 B1
6402784 Wardlaw et al. Jun 2002 B1
6413228 Hung et al. Jul 2002 B1
6419676 Zucherman et al. Jul 2002 B1
6419677 Zucherman et al. Jul 2002 B2
6440169 Elberg et al. Aug 2002 B1
6443988 Felt et al. Sep 2002 B2
6447547 Michelson Sep 2002 B1
6451019 Zucherman et al. Sep 2002 B1
6451020 Zucherman et al. Sep 2002 B1
6471976 Taylor et al. Oct 2002 B1
6478796 Zucherman et al. Nov 2002 B2
6478822 Leroux et al. Nov 2002 B1
6500178 Zucherman et al. Dec 2002 B2
6514256 Zucherman et al. Feb 2003 B2
6530925 Boudard et al. Mar 2003 B2
6558333 Gilboa et al. May 2003 B2
6565570 Sterett et al. May 2003 B2
6572617 Senegas et al. Jun 2003 B1
6575981 Boyd et al. Jun 2003 B1
6579319 Goble et al. Jun 2003 B2
6582433 Yun Jun 2003 B2
6582451 Marucci et al. Jun 2003 B1
6610065 Branch et al. Aug 2003 B1
6610091 Reiley Aug 2003 B1
6626944 Taylor et al. Sep 2003 B1
6645207 Dixon et al. Nov 2003 B2
6645211 Magana Nov 2003 B2
6652527 Zucherman et al. Nov 2003 B2
6652534 Zucherman et al. Nov 2003 B2
6679886 Weikel et al. Jan 2004 B2
6695842 Zucherman et al. Feb 2004 B2
6699246 Zucherman et al. Mar 2004 B2
6699247 Zucherman et al. Mar 2004 B2
6712819 Zucherman et al. Mar 2004 B2
6716245 Pasquet et al. Apr 2004 B2
6733534 Sherman May 2004 B2
6746485 Zucherman et al. Jun 2004 B1
6761720 Senegas et al. Jul 2004 B1
6769983 Slomiany Aug 2004 B2
6783529 Hover et al. Aug 2004 B2
6783546 Zucherman et al. Aug 2004 B2
6796983 Zucherman et al. Sep 2004 B1
6835205 Atkinson et al. Dec 2004 B2
6858029 Yeh et al. Feb 2005 B2
6869398 Obenchain et al. Mar 2005 B2
6875212 Shaolian et al. Apr 2005 B2
6902566 Zucherman et al. Jun 2005 B2
6926728 Zucherman et al. Aug 2005 B2
6946000 Senegas et al. Sep 2005 B2
6949123 Reiley Sep 2005 B2
6966930 Arnin et al. Nov 2005 B2
6974478 Reiley et al. Dec 2005 B2
7011685 Arnin et al. Mar 2006 B2
7029473 Zucherman et al. Apr 2006 B2
7033358 Taylor et al. Apr 2006 B2
7048736 Robinson et al. May 2006 B2
7070598 Lim et al. Jul 2006 B2
7083649 Zucherman et al. Aug 2006 B2
7087055 Lim et al. Aug 2006 B2
7087083 Pasquet et al. Aug 2006 B2
7097648 Globerman et al. Aug 2006 B1
7101375 Zucherman et al. Sep 2006 B2
7163558 Senegas et al. Jan 2007 B2
7179225 Shluzas et al. Feb 2007 B2
7187064 Tzu et al. Mar 2007 B2
7189234 Zucherman et al. Mar 2007 B2
7189236 Taylor et al. Mar 2007 B2
7201751 Zucherman et al. Apr 2007 B2
7217291 Zucherman et al. May 2007 B2
7223289 Trieu et al. May 2007 B2
7229441 Trieu et al. Jun 2007 B2
7238204 Le Couedic et al. Jul 2007 B2
7252673 Lim Aug 2007 B2
7273496 Mitchell Sep 2007 B2
7282063 Cohen et al. Oct 2007 B2
7297162 Mujwid Nov 2007 B2
7306628 Zucherman et al. Dec 2007 B2
7318839 Malberg et al. Jan 2008 B2
7320707 Zucherman et al. Jan 2008 B2
7335200 Carli Feb 2008 B2
7335203 Winslow et al. Feb 2008 B2
7354453 McAfee Apr 2008 B2
7384340 Eguchi et al. Jun 2008 B2
7410501 Michelson Aug 2008 B2
7442208 Mathieu et al. Oct 2008 B2
7445637 Taylor Nov 2008 B2
7473268 Zucherman et al. Jan 2009 B2
7476251 Zucherman et al. Jan 2009 B2
7481839 Zucherman et al. Jan 2009 B2
7481840 Zucherman et al. Jan 2009 B2
7491204 Marnay et al. Feb 2009 B2
7497859 Zucherman et al. Mar 2009 B2
7503935 Zucherman et al. Mar 2009 B2
7504798 Kawada et al. Mar 2009 B2
7510567 Zucherman et al. Mar 2009 B2
7520887 Maxy et al. Apr 2009 B2
7520899 Zucherman et al. Apr 2009 B2
7547308 Bertagnoli et al. Jun 2009 B2
7549999 Zucherman et al. Jun 2009 B2
7550009 Arnin et al. Jun 2009 B2
7565259 Sheng et al. Jul 2009 B2
7572276 Lim et al. Aug 2009 B2
7575600 Zucherman et al. Aug 2009 B2
7585313 Kwak et al. Sep 2009 B2
7585316 Trieu Sep 2009 B2
7588588 Spitler et al. Sep 2009 B2
7591851 Winslow et al. Sep 2009 B2
7601170 Winslow et al. Oct 2009 B2
7621939 Zucherman et al. Nov 2009 B2
7635377 Zucherman et al. Dec 2009 B2
7635378 Zucherman et al. Dec 2009 B2
7637950 Baccelli et al. Dec 2009 B2
7658752 Labrom et al. Feb 2010 B2
7662187 Zucherman et al. Feb 2010 B2
7666209 Zucherman et al. Feb 2010 B2
7666228 Le Couedic et al. Feb 2010 B2
7670377 Zucherman et al. Mar 2010 B2
7682376 Trieu Mar 2010 B2
7691146 Zucherman et al. Apr 2010 B2
7695513 Zucherman et al. Apr 2010 B2
7699852 Frankel et al. Apr 2010 B2
7699873 Stevenson et al. Apr 2010 B2
7727233 Blackwell et al. Jun 2010 B2
7742795 Stone et al. Jun 2010 B2
7749252 Zucherman et al. Jul 2010 B2
7749253 Zucherman et al. Jul 2010 B2
7753938 Aschmann et al. Jul 2010 B2
7758619 Zucherman et al. Jul 2010 B2
7758647 Arnin et al. Jul 2010 B2
7763028 Lim et al. Jul 2010 B2
7763050 Winslow et al. Jul 2010 B2
7763051 Labrom et al. Jul 2010 B2
7763073 Hawkins et al. Jul 2010 B2
7763074 Altarac et al. Jul 2010 B2
7766967 Francis Aug 2010 B2
7776090 Winslow et al. Aug 2010 B2
7780709 Bruneau et al. Aug 2010 B2
7789898 Peterman Sep 2010 B2
7794476 Wisnewski Sep 2010 B2
7803190 Zucherman et al. Sep 2010 B2
7806911 Peckham Oct 2010 B2
7811308 Arnin et al. Oct 2010 B2
7811322 Arnin et al. Oct 2010 B2
7811323 Arnin et al. Oct 2010 B2
7811324 Arnin et al. Oct 2010 B2
7811330 Arnin et al. Oct 2010 B2
7819921 Grotz Oct 2010 B2
7828822 Zucherman et al. Nov 2010 B2
7828849 Lim Nov 2010 B2
7833272 Arnin et al. Nov 2010 B2
7837688 Boyer, II et al. Nov 2010 B2
7837711 Bruneau et al. Nov 2010 B2
7837734 Zucherman et al. Nov 2010 B2
7846183 Blain Dec 2010 B2
7846185 Carls et al. Dec 2010 B2
7846186 Taylor Dec 2010 B2
7857815 Zucherman et al. Dec 2010 B2
7862569 Zucherman et al. Jan 2011 B2
7862586 Malek Jan 2011 B2
7862590 Lim et al. Jan 2011 B2
7862592 Peterson et al. Jan 2011 B2
7862615 Carli et al. Jan 2011 B2
7867276 Matge et al. Jan 2011 B2
7871426 Chin et al. Jan 2011 B2
20010031965 Zucherman et al. Oct 2001 A1
20020032447 Weikel et al. Mar 2002 A1
20020143331 Zucherman et al. Oct 2002 A1
20030040746 Mitchell et al. Feb 2003 A1
20030074075 Thomas et al. Apr 2003 A1
20030149438 Nichols et al. Aug 2003 A1
20030153976 Cauthen et al. Aug 2003 A1
20030176921 Lawson Sep 2003 A1
20030220643 Ferree Nov 2003 A1
20030220650 Major et al. Nov 2003 A1
20040087947 Lim et al. May 2004 A1
20040098048 Cunningham et al. May 2004 A1
20040167625 Beyar et al. Aug 2004 A1
20040220568 Zucherman et al. Nov 2004 A1
20050049708 Atkinson et al. Mar 2005 A1
20050075634 Zucherman et al. Apr 2005 A1
20050101955 Zucherman et al. May 2005 A1
20050125066 McAfee Jun 2005 A1
20050143738 Zucherman et al. Jun 2005 A1
20050165398 Reiley Jul 2005 A1
20050192586 Zucherman et al. Sep 2005 A1
20050192671 Bao et al. Sep 2005 A1
20050209603 Zucherman et al. Sep 2005 A1
20050216087 Zucherman et al. Sep 2005 A1
20050228383 Zucherman et al. Oct 2005 A1
20050228384 Zucherman et al. Oct 2005 A1
20050228426 Campbell Oct 2005 A1
20050245937 Winslow Nov 2005 A1
20060036258 Zucherman et al. Feb 2006 A1
20060064165 Zucherman et al. Mar 2006 A1
20060064166 Zucherman et al. Mar 2006 A1
20060074431 Sutton et al. Apr 2006 A1
20060084976 Borgstrom et al. Apr 2006 A1
20060084983 Kim Apr 2006 A1
20060084985 Kim Apr 2006 A1
20060084988 Kim Apr 2006 A1
20060084991 Borgstrom et al. Apr 2006 A1
20060085069 Kim Apr 2006 A1
20060085070 Kim Apr 2006 A1
20060085074 Raiszadeh Apr 2006 A1
20060089718 Zucherman et al. Apr 2006 A1
20060102269 Uchida et al. May 2006 A1
20060122620 Kim Jun 2006 A1
20060149254 Lauryssen et al. Jul 2006 A1
20060149289 Winslow et al. Jul 2006 A1
20060167416 Mathis et al. Jul 2006 A1
20060195102 Malandain Aug 2006 A1
20060217811 Lambrecht et al. Sep 2006 A1
20060224159 Anderson Oct 2006 A1
20060235386 Anderson Oct 2006 A1
20060241597 Mitchell et al. Oct 2006 A1
20060241614 Bruneau et al. Oct 2006 A1
20060241757 Anderson Oct 2006 A1
20060247623 Anderson et al. Nov 2006 A1
20060247632 Winslow et al. Nov 2006 A1
20060247633 Winslow et al. Nov 2006 A1
20060247650 Yerby et al. Nov 2006 A1
20060247773 Stamp Nov 2006 A1
20060264938 Zucherman et al. Nov 2006 A1
20060264939 Zucherman et al. Nov 2006 A1
20060265066 Zucherman et al. Nov 2006 A1
20060265067 Zucherman et al. Nov 2006 A1
20060271049 Zucherman et al. Nov 2006 A1
20060271055 Thramann Nov 2006 A1
20060271061 Beyar et al. Nov 2006 A1
20060271194 Zucherman et al. Nov 2006 A1
20060276801 Yerby et al. Dec 2006 A1
20060276897 Winslow et al. Dec 2006 A1
20060282077 Labrom et al. Dec 2006 A1
20060282078 Labrom et al. Dec 2006 A1
20070016196 Winslow et al. Jan 2007 A1
20070055237 Edidin et al. Mar 2007 A1
20070055246 Zucherman et al. Mar 2007 A1
20070073289 Kwak et al. Mar 2007 A1
20070100340 Lange et al. May 2007 A1
20070100366 Dziedzic et al. May 2007 A1
20070123863 Winslow et al. May 2007 A1
20070123904 Stad et al. May 2007 A1
20070161991 Altarac et al. Jul 2007 A1
20070161993 Lowery et al. Jul 2007 A1
20070173818 Hestad et al. Jul 2007 A1
20070173821 Trieu Jul 2007 A1
20070173822 Bruneau et al. Jul 2007 A1
20070173823 Dewey et al. Jul 2007 A1
20070173832 Tebbe et al. Jul 2007 A1
20070173939 Kim et al. Jul 2007 A1
20070179500 Chin et al. Aug 2007 A1
20070185490 Implicito Aug 2007 A1
20070191948 Arnin et al. Aug 2007 A1
20070198045 Morton et al. Aug 2007 A1
20070198091 Boyer et al. Aug 2007 A1
20070203493 Zucherman et al. Aug 2007 A1
20070203495 Zucherman et al. Aug 2007 A1
20070203496 Zucherman et al. Aug 2007 A1
20070203497 Zucherman et al. Aug 2007 A1
20070203501 Zucherman et al. Aug 2007 A1
20070208345 Marnay et al. Sep 2007 A1
20070208346 Marnay et al. Sep 2007 A1
20070208366 Pellegrino et al. Sep 2007 A1
20070225706 Clark et al. Sep 2007 A1
20070225724 Edmond Sep 2007 A1
20070225807 Phan et al. Sep 2007 A1
20070225814 Atkinson et al. Sep 2007 A1
20070233068 Bruneau et al. Oct 2007 A1
20070233074 Anderson et al. Oct 2007 A1
20070233076 Trieu Oct 2007 A1
20070233077 Khalili Oct 2007 A1
20070233081 Pasquet et al. Oct 2007 A1
20070233082 Chin et al. Oct 2007 A1
20070233083 Abdou Oct 2007 A1
20070233084 Betz et al. Oct 2007 A1
20070233088 Edmond Oct 2007 A1
20070233089 DiPoto et al. Oct 2007 A1
20070233096 Garcia-Bengochea Oct 2007 A1
20070233098 Mastrorio et al. Oct 2007 A1
20070233129 Bertagnoli et al. Oct 2007 A1
20070250060 Anderson et al. Oct 2007 A1
20070260245 Malandain et al. Nov 2007 A1
20070265623 Malandain et al. Nov 2007 A1
20070265624 Zucherman et al. Nov 2007 A1
20070265625 Zucherman et al. Nov 2007 A1
20070265626 Seme Nov 2007 A1
20070270822 Heinz Nov 2007 A1
20070270823 Trieu et al. Nov 2007 A1
20070270824 Lim et al. Nov 2007 A1
20070270826 Trieu et al. Nov 2007 A1
20070270827 Lim et al. Nov 2007 A1
20070270828 Bruneau et al. Nov 2007 A1
20070270829 Carls et al. Nov 2007 A1
20070270834 Bruneau et al. Nov 2007 A1
20070272259 Allard et al. Nov 2007 A1
20070276368 Trieu et al. Nov 2007 A1
20070276369 Allard et al. Nov 2007 A1
20070276370 Altarac et al. Nov 2007 A1
20070276372 Malandain et al. Nov 2007 A1
20070276373 Malandain Nov 2007 A1
20070276493 Malandain et al. Nov 2007 A1
20070276496 Lange et al. Nov 2007 A1
20070276497 Anderson Nov 2007 A1
20070276500 Zucherman et al. Nov 2007 A1
20080015700 Zucherman et al. Jan 2008 A1
20080021468 Zucherman et al. Jan 2008 A1
20080021560 Zucherman et al. Jan 2008 A1
20080021561 Zucherman et al. Jan 2008 A1
20080027545 Zucherman et al. Jan 2008 A1
20080027552 Zucherman et al. Jan 2008 A1
20080027553 Zucherman et al. Jan 2008 A1
20080033445 Zucherman et al. Feb 2008 A1
20080033553 Zucherman et al. Feb 2008 A1
20080033558 Zucherman et al. Feb 2008 A1
20080033559 Zucherman et al. Feb 2008 A1
20080039853 Zucherman et al. Feb 2008 A1
20080039858 Zucherman et al. Feb 2008 A1
20080039859 Zucherman et al. Feb 2008 A1
20080039945 Zucherman et al. Feb 2008 A1
20080039946 Zucherman et al. Feb 2008 A1
20080039947 Zucherman et al. Feb 2008 A1
20080045958 Zucherman et al. Feb 2008 A1
20080045959 Zucherman et al. Feb 2008 A1
20080046081 Zucherman et al. Feb 2008 A1
20080046085 Zucherman et al. Feb 2008 A1
20080046086 Zucherman et al. Feb 2008 A1
20080046087 Zucherman et al. Feb 2008 A1
20080046088 Zucherman et al. Feb 2008 A1
20080051785 Zucherman et al. Feb 2008 A1
20080051898 Zucherman et al. Feb 2008 A1
20080051899 Zucherman et al. Feb 2008 A1
20080051904 Zucherman et al. Feb 2008 A1
20080051905 Zucherman et al. Feb 2008 A1
20080058806 Klyce et al. Mar 2008 A1
20080058807 Klyce et al. Mar 2008 A1
20080058808 Klyce et al. Mar 2008 A1
20080058941 Zucherman et al. Mar 2008 A1
20080065086 Zucherman et al. Mar 2008 A1
20080065212 Zucherman et al. Mar 2008 A1
20080065213 Zucherman et al. Mar 2008 A1
20080065214 Zucherman et al. Mar 2008 A1
20080071378 Zucherman et al. Mar 2008 A1
20080086212 Zucherman et al. Apr 2008 A1
20080167655 Wang et al. Jul 2008 A1
20080167656 Zucherman et al. Jul 2008 A1
20080172057 Zucherman et al. Jul 2008 A1
20080177272 Zucherman et al. Jul 2008 A1
20080183210 Zucherman et al. Jul 2008 A1
20080188895 Cragg et al. Aug 2008 A1
20080195152 Altarac et al. Aug 2008 A1
20080208344 Kilpela et al. Aug 2008 A1
20080215058 Zucherman et al. Sep 2008 A1
20080221692 Zucherman et al. Sep 2008 A1
20080228225 Trautwein et al. Sep 2008 A1
20080234824 Youssef et al. Sep 2008 A1
20080287997 Altarac et al. Nov 2008 A1
20080288075 Zucherman et al. Nov 2008 A1
20080294263 Altarac et al. Nov 2008 A1
20080319550 Altarac et al. Dec 2008 A1
20090118833 Hudgins et al. May 2009 A1
20090125030 Tebbe et al. May 2009 A1
20090138046 Altarac et al. May 2009 A1
20090138055 Altarac et al. May 2009 A1
20090248079 Kwak et al. Oct 2009 A1
20090292315 Trieu Nov 2009 A1
20100042217 Zucherman et al. Feb 2010 A1
20100082108 Zucherman et al. Apr 2010 A1
20100262243 Zucherman et al. Oct 2010 A1
20100305611 Zucherman et al. Dec 2010 A1
Foreign Referenced Citations (103)
Number Date Country
69507480 Sep 1999 DE
322334 Jun 1989 EP
0767636 Apr 1997 EP
0768843 Apr 1997 EP
0959792 Dec 1999 EP
1027004 Aug 2000 EP
1030615 Aug 2000 EP
1138268 Oct 2001 EP
1330987 Jul 2003 EP
1056408 Dec 2003 EP
1343424 Sep 2004 EP
1454589 Sep 2004 EP
1148850 Apr 2005 EP
1299042 Mar 2006 EP
1578314 May 2007 EP
1675535 May 2007 EP
WO-9404088 Mar 1994 WO
WO-9426192 Nov 1994 WO
WO-9525485 Sep 1995 WO
WO-9531158 Nov 1995 WO
WO-9600049 Jan 1996 WO
WO-9829047 Jul 1998 WO
WO-9921500 May 1999 WO
WO-9921501 May 1999 WO
WO-9942051 Aug 1999 WO
WO-0013619 Mar 2000 WO
WO-0044319 Aug 2000 WO
WO-0044321 Aug 2000 WO
WO-0128442 Apr 2001 WO
WO-0191657 Dec 2001 WO
WO-0191658 Dec 2001 WO
WO-0203882 Jan 2002 WO
WO-0207623 Jan 2002 WO
WO-0207624 Jan 2002 WO
WO-02051326 Jul 2002 WO
WO-02067793 Sep 2002 WO
WO-02071960 Sep 2002 WO
WO-02076336 Oct 2002 WO
WO-03007791 Jan 2003 WO
WO-03007829 Jan 2003 WO
WO-03008016 Jan 2003 WO
WO-03015646 Feb 2003 WO
WO-03024298 Mar 2003 WO
WO-03045262 Jun 2003 WO
WO-03099147 Dec 2003 WO
WO-03101350 Dec 2003 WO
WO-2004073533 Sep 2004 WO
WO-2004110300 Dec 2004 WO
WO-2005009300 Feb 2005 WO
WO-2005013839 Feb 2005 WO
WO-2005025461 Mar 2005 WO
WO-2005041799 May 2005 WO
WO-2005044152 May 2005 WO
WO-2005055868 Jun 2005 WO
WO-2005079672 Sep 2005 WO
WO-2005115261 Dec 2005 WO
WO-2006033659 Mar 2006 WO
WO-2006034423 Mar 2006 WO
WO-2006039243 Apr 2006 WO
WO-2006039260 Apr 2006 WO
WO-2006045094 Apr 2006 WO
WO-2006063047 Jun 2006 WO
WO-2006065774 Jun 2006 WO
WO-2006102269 Sep 2006 WO
WO-2006102428 Sep 2006 WO
WO-2006102485 Sep 2006 WO
WO-2006107539 Oct 2006 WO
WO-2006110462 Oct 2006 WO
WO-2006110464 Oct 2006 WO
WO-2006110767 Oct 2006 WO
WO-2006113080 Oct 2006 WO
WO-2006113406 Oct 2006 WO
WO-2006113814 Oct 2006 WO
WO-2006118945 Nov 2006 WO
WO-2006119235 Nov 2006 WO
WO-2006119236 Nov 2006 WO
WO-2006135511 Dec 2006 WO
WO-2007015028 Feb 2007 WO
WO-2007035120 Mar 2007 WO
WO-2007075375 Jul 2007 WO
WO-2007075788 Jul 2007 WO
WO-2007075791 Jul 2007 WO
WO-2007089605 Aug 2007 WO
WO-2007089905 Aug 2007 WO
WO-2007089975 Aug 2007 WO
WO-2007097735 Aug 2007 WO
WO-2007109402 Sep 2007 WO
WO-2007110604 Oct 2007 WO
WO-2007111795 Oct 2007 WO
WO-2007111979 Oct 2007 WO
WO-2007111999 Oct 2007 WO
WO-2007117882 Oct 2007 WO
WO-2007121070 Oct 2007 WO
WO-2007127550 Nov 2007 WO
WO-2007127588 Nov 2007 WO
WO-2007127677 Nov 2007 WO
WO-2007127689 Nov 2007 WO
WO-2007127694 Nov 2007 WO
WO-2007127734 Nov 2007 WO
WO-2007127736 Nov 2007 WO
WO-2007131165 Nov 2007 WO
WO-2007134113 Nov 2007 WO
WO-2008048645 Apr 2008 WO
Non-Patent Literature Citations (55)
Entry
Final Office Action; U.S. Appl. No. 10/970,843; Mailing Date: Feb. 12, 2009, 7 pages.
Final Office Action; U.S. Appl. No. 10/970,843; Mailing Date: Jul. 2, 2010, 9 pages.
Final Office Action; U.S. Appl. No. 11/006,502; Mailing Date: Aug. 17, 2009, 7 pages.
Final Office Action; U.S. Appl. No. 11/006,521; Mailing Date: May 17, 2010, 10 pages.
Final Office Action; U.S. Appl. No. 11/006,521; Mailing Date: Dec. 5, 2008, 10 pages.
Final Office Action; U.S. Appl. No. 11/052,002; Mailing Date: Apr. 1, 2009, 7 pages.
Final Office Action; U.S. Appl. No. 11/052,002; Mailing Date: Sep. 1, 2010, 7 pages.
Final Office Action; U.S. Appl. No. 11/079,006; Mailing Date: Nov. 10, 2009, 7 pages.
Final Office Action; U.S. Appl. No. 11/190,496; Mailing Date: May 19, 2009, 8 pages.
Final Office Action; U.S. Appl. No. 11/305,820; Mailing Date: Jun. 16, 2008, 9 pages.
Final Office Action; U.S. Appl. No. 11/314,712; Mailing Date: Sep. 4, 2009, 9 pages.
Final Office Action; U.S. Appl. No. 11/582,874; Mailing Date: Sep. 10, 2010, 10 pages.
International Search Report and Written Opinion; Application No. PCT/US2005/038026; Mailing Date: Apr. 22, 2008, 9 pages.
International Search Report and Written Opinion; Application No. PCT/US2005/044256; Mailing Date: Jul. 28, 2006, 7 pages.
International Search Report and Written Opinion; Application No. PCT/US2006/047824; Mailing Date: Oct. 16, 2008, 3 pages.
International Search Report and Written Opinion; Application No. PCT/US2006/048611; Mailing Date: Oct. 14, 2008; 10 pages.
International Search Report and Written Opinion; Application No. PCT/US2006/048614; Mailing Date: Feb. 3, 2006; 23 pages.
International Search Report and Written Opinion; Application No. PCT/US2007/022171; Mailing Date: Apr. 15, 2008, 13 pages.
International Search Report and Written Opinion; Application No. PCT/US2007/023312; Mailing Date: May 22, 2008, 14 pages.
International Search Report and Written Opinion; Application No. PCT/US2008/004901; Mailing Date: Aug. 19, 2008, 7 pages.
International Search Report and Written Opinion; Application No. PCT/US2008/008382; Mailing Date: Mar. 2, 2009, 12 pages.
International Search Report and Written Opinion; Application No. PCT/US2008/008983; Mailing Date: Feb. 23, 2009, 7 pages.
International Search Report and Written Opinion; Application No. PCT/US2008/075487; Mailing Date: Dec. 31, 2008, 7 pages.
International Search Report and Written Opinion; Application No. PCT/US2008/087527; Mailing Date: Jul. 30, 2009, 7 pages.
International Search Report and Written Opinion; Application No. PCT/US2009/031150; Mailing Date: Aug. 28, 2009, 5 pages.
International Search Report and Written Opinion; Application No. PCT/US2009/031710; Mailing Date: Sep. 1, 2009, 10 pages.
International Search Report and Written Opinion; Application No. PCT/US2009/036561; Mailing Date: Sep. 17, 2009, 12 pages.
Minns, R.J., et al., “Preliminary Design and Experimental Studies of a Noval Soft Implant for Correcting Sagittal Plane Instability in the Lumbar Spine,” (1997) Spine, 22(16): 1819-1827.
Non-Final Office Action; U.S. Appl. No. 10/970,843; Mailing Date: Aug. 29, 2008, 9 pages.
Non-Final Office Action; U.S. Appl. No. 10/970,843; Mailing Date: Oct. 8, 2009, 8 pages.
Non-Final Office Action; U.S. Appl. No. 11/006,502; Mailing Date: Nov. 7, 2008, 7 pages.
Non-Final Office Action; U.S. Appl. No. 11/006,521; Mailing Date: Feb. 28, 2008, 13 pages.
Non-Final Office Action; U.S. Appl. No. 11/006,521; Mailing Date: Aug. 26, 2009, 9 pages.
Non-Final Office Action; U.S. Appl. No. 11/052,002; Mailing Date: Sep. 18, 2007, 7 pages.
Non-Final Office Action; U.S. Appl. No. 11/052,002; Mailing Date: Dec. 24, 2009, 6 pages.
Non-Final Office Action; U.S. Appl. No. 11/079,006; Mailing Date: Jan. 30, 2009, 7 pages.
Non-Final Office Action; U.S. Appl. No. 11/079,006; Mailing Date: Sep. 18, 2007, 6 pages.
Non-Final Office Action; U.S. Appl. No. 11/190,496; Mailing Date: Aug. 25, 2008, 6 pages.
Non-Final Office Action; U.S. Appl. No. 11/190,496; Mailing Date: Oct. 31, 2007, 7 pages.
Non-Final Office Action; U.S. Appl. No. 11/305,820; Mailing Date: Oct. 9, 2007, 8 pages.
Non-Final Office Action; U.S. Appl. No. 11/314,712; Mailing Date: Jan. 21, 2009, 8 pages.
Non-Final Office Action; U.S. Appl. No. 11/582,874; Mailing Date: Jan. 4, 2010, 9 pages.
Non-Final Office Action; U.S. Appl. No. 11/593,995; Mailing Date: Apr. 19, 2010, 10 pages.
Non-Final Office Action; U.S. Appl. No. 12/338,793; Mailing Date: Sep. 21, 2010, 9 pages.
Supplementary European Search Report; Application No. EP05849654.8; Applicant: Vertiflex, Inc; Date of Completion: May 15, 2009, 10 pages.
Supplementary European Search Report; Application No. EP07861721.4; Applicant: Vertiflex, Inc; Date of Completion: Nov. 24, 2009, 6 pages.
Supplementary European Search Report; Application No. EP09170304.1; Applicant: Vertiflex, Inc; Date of Completion: Nov. 11, 2009, 5 pages.
Supplementary European Search Report; Application No. EP09170338.9; Applicant: Vertiflex, Inc; Date of Completion: Nov. 12, 2009, 6 pages.
Swan, Colby, “Preliminary Design and Experimental Studies of a Novel Soft Implant for Correcting Sogittal P{lane Instability in the Lumbar Spine,” Spine, 1997, 22(16), 1826-1827.
International Search Report and Written Opinion for application No. PCT/US09/031710, Mail Date Sep. 1, 2009, 10 pages.
European Office Action Application No. EP05849654.8; Applicant: The Board of Trustees of the Leland Stanford Junior University; Date of Completion: Jun. 21, 2011, 4 pages.
Non-Final Office Action; U.S. Appl. No. 12/205,511 Mailing Date: Apr. 20, 2011 9 pages.
Supplementary European Search Report; Application No. EP07861426.0; Applicant: Vertiflex, Inc; Date of Completion: Jun. 7, 2011, 6 pages.
Supplementary European Search Report; Application No. EP09702116.6; Applicant: Vertiflex, Inc; Date of Completion: Feb. 11, 2011, 6 pages.
Supplementary European Search Report; Application No. EP11151901.3; Applicant: Vertiflex, Inc; Date of Completion: Apr. 7, 2011, 6 pages.
Related Publications (1)
Number Date Country
20090125030 A1 May 2009 US
Provisional Applications (1)
Number Date Country
61062448 Jan 2008 US
Continuation in Parts (1)
Number Date Country
Parent 11582874 Oct 2006 US
Child 12358010 US